242 filings
Page 10 of 13
8-K
8txxks1lb5k 4lof
7 Dec 17
Other Events
12:00am
EFFECT
28h3q cydrmyei
4 Dec 17
Notice of effectiveness
12:00am
CORRESP
a4il21g6v0yaschi2em
1 Dec 17
Correspondence with SEC
12:00am
UPLOAD
pwfuke
1 Dec 17
Letter from SEC
12:00am
CORRESP
2pba3w87wuskjne 4std
1 Dec 17
Correspondence with SEC
12:00am
S-3/A
nhyuzbgflut
1 Dec 17
Shelf registration (amended)
12:00am
8-K
ci8nza657fxkgbuhe
13 Nov 17
CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer
12:00am
S-3
ifamy5z91do3l9g2avu
9 Nov 17
Shelf registration
12:00am
S-8
r2c 2yknz
8 Nov 17
Registration of securities for employees
12:00am
8-K
woww03gltkv
8 Nov 17
CRISPR Therapeutics Announces Third Quarter 2017 Financial Results
12:00am
8-K
1drynv
7 Nov 17
Other Events
12:00am
8-K
htask
2 Oct 17
CRISPR Therapeutics Announces Promotion of
12:00am
8-K
tupom
10 Aug 17
CRISPR Therapeutics Announces Second Quarter 2017 Financial Results
12:00am
8-K
iblw 1nazj
1 Aug 17
CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development
12:00am
8-K
3gm6owo
27 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
9h83yc wv
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
hbu23iffoa
25 Jul 17
Other Events
12:00am
8-K
al4dpm 9129859huyc6
19 Jun 17
CRISPR Therapeutics Announces Patent
12:00am